title: The role of combination therapy in type 2 diabetes in the post-ACCORD era.
authors.affiliation: The University of Florida, Gainesville, FL, USA. lkuritzky@aol.com
authors.forename: Louis
authors.initials: L
authors.lastname: Kuritzky
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000097:blood / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000517:prevention & control; D003929:Diabetic Neuropathies / Q000517:prevention & control; D003930:Diabetic Retinopathy / Q000517:prevention & control; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D000077270:Exenatide; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D008687:Metformin; D000077270:Exenatide